ARYx Therapeutics, Inc. (ARYX)

ARYx Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005
Period Ending	Sep 30, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007	Dec 31, 2006	Dec 31, 2005
Net Income	-18.33	-33.17	-31.22	-27.56	-27.33	-27.96
Depreciation & Amortization	0.95	1.08	1.1	1.01	0.83	0.56
Asset Writedown & Restructuring Costs	-0.01	0.02	-	0.01	0.11	0.01
Loss (Gain) From Sale of Investments	0.18	0.2	0.2	-0.01	-0.01	0.02
Stock-Based Compensation	0.98	1.93	2.15	1.21	0.63	0.42
Other Operating Activities	0.24	0.22	0.3	-0.21	0.1	0.4
Change in Accounts Payable	-2.06	-1.7	0.85	0.96	0.09	-1.2
Change in Unearned Revenue	-	-	-19.5	-3.88	23.38	-
Change in Other Net Operating Assets	-2.03	-3.56	0.9	0.76	-2.01	5.33
Operating Cash Flow	-20.07	-34.97	-45.22	-27.71	-4.21	-22.43
Capital Expenditures	-0.05	-0.14	-0.64	-0.5	-0.96	-3.85
Investment in Securities	7.68	8.36	-1.47	24.02	-17.74	13.37
Other Investing Activities	0.49	0.2	-0.3	-0.15	0.19	-
Investing Cash Flow	8.11	8.41	-2.41	23.37	-18.51	9.53
Long-Term Debt Issued	-	-	10	-	0.68	11.18
Long-Term Debt Repaid	-	-2.99	-2.3	-2.9	-1.97	-0.09
Net Debt Issued (Repaid)	0.82	-2.99	7.7	-2.9	-1.29	11.09
Issuance of Common Stock	7.46	1.26	20.45	44.05	0.06	0.09
Other Financing Activities	-0.22	-0.31	-	-	-	-
Financing Cash Flow	8.07	-2.04	28.15	41.15	28.93	11.18
Net Cash Flow	-3.89	-28.59	-19.48	36.82	6.21	-1.73
Free Cash Flow	-20.12	-35.11	-45.86	-28.2	-5.18	-26.28
Free Cash Flow Margin	-	-	-232.52%	-678.31%	-109.20%	-
Free Cash Flow Per Share	-0.65	-1.28	-2.42	-8.43	-5.08	-28.88
Cash Interest Paid	1.33	1.33	1.18	0.81	0.94	0.19
Levered Free Cash Flow	-10.64	-21.47	-19.4	-16.22	-14.91	-
Unlevered Free Cash Flow	-9.58	-20.22	-18.2	-15.38	-14.08	-
Change in Working Capital	-4.09	-5.25	-17.74	-2.16	21.46	4.13

Source: S&P Global Market Intelligence. Standard template. Financial Sources.